_version_ 1819097826752200704
author Eskild Petersen
Francine Ntoumi
David S Hui
Aisha Abubakar
Laura D. Kramer
Christina Obiero
Paul Anantharajah Tambyah
Lucille Blumberg
Richard Yapi
Seif Al-Abri
Tatiana de Castro Abreu Pinto
Dorothy Yeboah-Manu
Najmul Haider
Danny Asogun
Thirumalaisamy P. Velavan
Nathan Kapata
Matthew Bates
Rashid Ansumana
Chiara Montaldo
Luchenga Mucheleng'anga
John Tembo
Peter Mwaba
Cordelia M. Himwaze
Muzamil Mahdi Abdel Hamid
Sayoki Mfinanga
Leonard Mboera
Tajudeen Raj
Eleni Aklillu
Francisco Veas
Sarah Edwards
Pontiano Kaleebu
Timothy D. McHugh
Jeremiah Chakaya
Thomas Nyirenda
Moses Bockarie
Peter S Nyasulu
Christian Wejse
Jean-Jacques Muyembe-Tamfum
Esam I. Azhar
Markus Maeurer
Jean B. Nachega
Richard Kock
Giuseppe Ippolito
Alimuddin Zumla
author_facet Eskild Petersen
Francine Ntoumi
David S Hui
Aisha Abubakar
Laura D. Kramer
Christina Obiero
Paul Anantharajah Tambyah
Lucille Blumberg
Richard Yapi
Seif Al-Abri
Tatiana de Castro Abreu Pinto
Dorothy Yeboah-Manu
Najmul Haider
Danny Asogun
Thirumalaisamy P. Velavan
Nathan Kapata
Matthew Bates
Rashid Ansumana
Chiara Montaldo
Luchenga Mucheleng'anga
John Tembo
Peter Mwaba
Cordelia M. Himwaze
Muzamil Mahdi Abdel Hamid
Sayoki Mfinanga
Leonard Mboera
Tajudeen Raj
Eleni Aklillu
Francisco Veas
Sarah Edwards
Pontiano Kaleebu
Timothy D. McHugh
Jeremiah Chakaya
Thomas Nyirenda
Moses Bockarie
Peter S Nyasulu
Christian Wejse
Jean-Jacques Muyembe-Tamfum
Esam I. Azhar
Markus Maeurer
Jean B. Nachega
Richard Kock
Giuseppe Ippolito
Alimuddin Zumla
author_sort Eskild Petersen
collection DOAJ
first_indexed 2024-12-22T00:21:16Z
format Article
id doaj.art-b530659a78a94415aee96b052c5f2c7c
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-12-22T00:21:16Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-b530659a78a94415aee96b052c5f2c7c2022-12-21T18:45:10ZengElsevierInternational Journal of Infectious Diseases1201-97122022-01-01114268272Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control effortsEskild Petersen0Francine Ntoumi1David S Hui2Aisha Abubakar3Laura D. Kramer4Christina Obiero5Paul Anantharajah Tambyah6Lucille Blumberg7Richard Yapi8Seif Al-Abri9Tatiana de Castro Abreu Pinto10Dorothy Yeboah-Manu11Najmul Haider12Danny Asogun13Thirumalaisamy P. Velavan14Nathan Kapata15Matthew Bates16Rashid Ansumana17Chiara Montaldo18Luchenga Mucheleng'anga19John Tembo20Peter Mwaba21Cordelia M. Himwaze22Muzamil Mahdi Abdel Hamid23Sayoki Mfinanga24Leonard Mboera25Tajudeen Raj26Eleni Aklillu27Francisco Veas28Sarah Edwards29Pontiano Kaleebu30Timothy D. McHugh31Jeremiah Chakaya32Thomas Nyirenda33Moses Bockarie34Peter S Nyasulu35Christian Wejse36Jean-Jacques Muyembe-Tamfum37Esam I. Azhar38Markus Maeurer39Jean B. Nachega40Richard Kock41Giuseppe Ippolito42Alimuddin Zumla43European Society for Clinical Microbiology and Infectious Diseases, Emerging Infections Task Force, ESCMID, Basel, Switzerland; Institute for Clinical Medicine, Aarhus University, Denmark; European Travel Medicine Network, Méditerranée Infection Foundation, Marseille, France; Corresponding author: Professor Eskild Petersen: European Society for Clinical Microbiology and Infectious Diseases, Emerging Infections Task Force, ESCMID, Basel, Switzerland; Institute for Clinical Medicine, Aarhus University, Denmark; European Travel Medicine Network, Méditerranée Infection Foundation, Marseille, France.Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Republic of Congo; Institute for Tropical Medicine, University of Tübingen, GermanyDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong KongAhmadu Bello University, Zaria, NigeriaSchool of Public Health, State University at Albany, Albany, New York, USAInternational Society for Infectious Diseases, Boston, United States; Clinical Research Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Depart of Global Health, University of Amsterdam, Amsterdam, Noord-Holland, The NetherlandsInternational Society for Infectious Diseases, Boston, United States; Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, SingaporeDivision of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg South AfricaInternational Society for Infectious Diseases, Boston, United States; Centre d'Entomologie Médicale et Vétérinaire, CEMV – Université Alassane Ouattara, Bouaké, Côte d'IvoireInternational Society for Infectious Diseases, Boston, United States; Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, OmanInternational Society for Infectious Diseases, Boston, United States; Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, BrazilNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, GhanaPathobiology and Population Science, The Royal Veterinary College, London, United KingdomCommunity Medicine, Irrua Specialist Teaching Hospital, Irrua, Edo, NigeriaInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany; and Vietnamese-German Center of Medical Research, Hanoi, VietnamNational Public Health Institute, Ministry of Health, and UNZA-UCLMS Research and Training Program, Lusaka, ZambiaHerpeZ and UNZA-UCLMS Project, University Teaching Hospital, Lusaka, Zambia; and School of Life Sciences, University of Lincoln, Lincoln, UKMercy Hospital Research Laboratory, Bo, Freetown, Sierra LeoneNational Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, ItalyMinistry of Home Affairs, Office of the State Forensic Pathologist, and UNZA-UCLMS Research and Training Program, University Teaching Hospital, Lusaka, ZambiaHERPEZ and UNZA-UCLMS Research and Training Program, University Teaching Hospital, Lusaka, ZambiaLusaka Apex Medical University, Faculty of Medicine, and UNZA-UCLMS Research and Training Project, Lusaka, ZambiaUniversity Teaching Hospital, Department of Pathology and Microbiology; and UNZA-UCLMS Research and Training Program, University Teaching Hospital, Lusaka, ZambiaDepartment of Parasitology and Medical Entomology, Institute of Endemic Diseases, University of Khartoum, Khartoum, SudanMuhimbili Medical Research Centre National Institute for Medical Research, Dar es Salaam, TanzaniaSACIDS Foundation for One Health, Sokoine, University of Agriculture, Morogoro, TanzaniaDivision of Public Health Institutes and Research, Africa Centres for Disease Control and Prevention, Addis Ababa, EthiopiaDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital-Huddinge, Karolinska Institute, Stockholm, SwedenMolecular Comparative Immuno-Physiopathology Lab), Joint Research Unit-Ministry of Defense, Faculty of Pharmacy, French Research Institute for Development (IRD), Montpellier University, Montpellier, FranceEthics and Governance, University College London, London, United KingdomMedical Research Council/Uganda Virus Research Institute, Entebbe, UgandaCenter for Clinical Microbiology, Division of Infection and Immunity, University College London, London, United KingdomDepartment of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, KenyaEuropean and Developing Countries clinical trials Partnership, EDCTP Africa Office, Cape Town, South AfricaEuropean and Developing Countries clinical trials Partnership, EDCTP Africa Office, Cape Town, South AfricaDivision of Epidemiology & Biostatistics, Faculty of Medicine; Health Sciences, Stellenbosch University, Cape Town, South AfricaDepartment of Infectious Diseases, Institute of Publich Health, Aarhus University Hospital, Skejby, DenmarkNational Institute of Biomedical Research and Department of Medical Microbiology and Virology, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the CongoSpecial Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University; Dept. of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi ArabiaImmunoSurgery Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal; Medizinische Klinik, Johannes Gutenberg University Mainz, GermanyDepartment of Medicine and Division of Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa, and Depts of Epidemiology, Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USAThe Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, UKGeneral Directorate for Research and Innovation in Health, Ministry of Health, Rome, ItalyCenter for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdomhttp://www.sciencedirect.com/science/article/pii/S1201971221008882
spellingShingle Eskild Petersen
Francine Ntoumi
David S Hui
Aisha Abubakar
Laura D. Kramer
Christina Obiero
Paul Anantharajah Tambyah
Lucille Blumberg
Richard Yapi
Seif Al-Abri
Tatiana de Castro Abreu Pinto
Dorothy Yeboah-Manu
Najmul Haider
Danny Asogun
Thirumalaisamy P. Velavan
Nathan Kapata
Matthew Bates
Rashid Ansumana
Chiara Montaldo
Luchenga Mucheleng'anga
John Tembo
Peter Mwaba
Cordelia M. Himwaze
Muzamil Mahdi Abdel Hamid
Sayoki Mfinanga
Leonard Mboera
Tajudeen Raj
Eleni Aklillu
Francisco Veas
Sarah Edwards
Pontiano Kaleebu
Timothy D. McHugh
Jeremiah Chakaya
Thomas Nyirenda
Moses Bockarie
Peter S Nyasulu
Christian Wejse
Jean-Jacques Muyembe-Tamfum
Esam I. Azhar
Markus Maeurer
Jean B. Nachega
Richard Kock
Giuseppe Ippolito
Alimuddin Zumla
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
International Journal of Infectious Diseases
title Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
title_full Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
title_fullStr Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
title_full_unstemmed Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
title_short Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
title_sort emergence of new sars cov 2 variant of concern omicron b 1 1 529 highlights africa s research capabilities but exposes major knowledge gaps inequities of vaccine distribution inadequacies in global covid 19 response and control efforts
url http://www.sciencedirect.com/science/article/pii/S1201971221008882
work_keys_str_mv AT eskildpetersen emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT francinentoumi emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT davidshui emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT aishaabubakar emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT lauradkramer emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT christinaobiero emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT paulanantharajahtambyah emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT lucilleblumberg emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT richardyapi emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT seifalabri emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT tatianadecastroabreupinto emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT dorothyyeboahmanu emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT najmulhaider emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT dannyasogun emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT thirumalaisamypvelavan emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT nathankapata emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT matthewbates emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT rashidansumana emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT chiaramontaldo emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT luchengamuchelenganga emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT johntembo emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT petermwaba emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT cordeliamhimwaze emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT muzamilmahdiabdelhamid emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT sayokimfinanga emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT leonardmboera emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT tajudeenraj emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT eleniaklillu emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT franciscoveas emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT sarahedwards emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT pontianokaleebu emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT timothydmchugh emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT jeremiahchakaya emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT thomasnyirenda emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT mosesbockarie emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT petersnyasulu emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT christianwejse emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT jeanjacquesmuyembetamfum emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT esamiazhar emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT markusmaeurer emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT jeanbnachega emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT richardkock emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT giuseppeippolito emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts
AT alimuddinzumla emergenceofnewsarscov2variantofconcernomicronb11529highlightsafricasresearchcapabilitiesbutexposesmajorknowledgegapsinequitiesofvaccinedistributioninadequaciesinglobalcovid19responseandcontrolefforts